LSP1 and invasive breast carcinoma: ,57,58 These data, combined with genetic evidence that the LSP1 locus is associated with altered LSP1 expression in leukocytes and BrCa-specific outcomes, suggest that LSP1 is a iTME modifier of BrCa incidence and disease progression.